Pharmaceutical

Attorney Brendan A. Smith Discusses the Latest Legal Developments in Pharmaceutical Litigation on DrugWatch.com

by

Miami, FL – The future of pain management is being reshaped by the evolving potential of medical marijuana, presenting an alternative to traditional pharmaceuticals and offering new hope to those suffering from chronic pain. In recent years, advocacy and research around the use of cannabis for medicinal purposes have gained significant momentum, influencing legislation and medical perspectives alike. Medical marijuana, legalized in several states across the nation, has been found potentially beneficial in treating conditions ranging from chronic pain to epilepsy and multiple sclerosis. Studies suggest that cannabinoids—the active compounds in marijuana—can act as effective … Read more

Pharmaceutical Giants Challenge Delaware Court Over Expert Testimony in Zantac Case, Fear Increase in Mass Tort Filings

by

Dover, Delaware — Leading pharmaceutical giants are urging Delaware’s highest court to reconsider a lower court’s decision that greenlit expert testimony in ongoing Zantac litigation, claiming the ruling misaligns with established federal standards. Companies like GlaxoSmithKline, Pfizer, Sanofi, and Boehringer Ingelheim, which are part of the lawsuit focused on the heartburn medication Zantac, fear it could transform Delaware into a hotbed for mass tort litigation. Represented by distinguished law firms including Dechert, Williams & Connolly, DLA Piper, and King & Spalding, these pharmaceutical heavyweights find the Superior Court’s decision unsettling. The ruling by Superior Court … Read more

FDA Program Allows Importation of Health Canada-Approved Drugs, Opening New Opportunities for Pharmaceutical Access

by

Miami, Florida – The importation of drugs approved by Health Canada into the United States may become a reality under a new program established by the FDA. Recently, the FDA approved a proposal for the Section 804 Importation Program (SIP) in Florida, making it the first state to receive approval for importing pharmaceuticals approved by a foreign regulator. This groundbreaking move could pave the way for other states, like Colorado, to seek FDA approval for similar programs. While the availability of Canadian-approved drugs in the US is promising, it presents unique challenges for foreign manufacturers … Read more

Federal Judge Dismisses Pharmaceutical Industry Lawsuit Over Medicare Drug Pricing Program

by

Austin, Texas – A federal judge in Austin has dismissed a lawsuit brought by pharmaceutical industry bodies challenging a new Medicare program that allows the government to negotiate prices for expensive drugs. U.S. District Judge David Ezra, appointed by Ronald Reagan, sided with the Biden administration in throwing out the lawsuit. The Pharmaceutical Research and Manufacturers of America (PhRMA) group and two others had claimed the program was unconstitutional. Under the program, known as the Inflation Reduction Act, the Department of Health and Human Services is authorized to seek lower prices for certain drugs, ultimately … Read more